Ever want to scream during a particularly bad day, but then manage not to? Thank the human brain and how it regulates emotions, which can be critical for navigating everyday life. As we perceive events unfolding around us, ...
Apr 3, 2024
0
97
New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said Wednesday.
Apr 3, 2024
0
17
Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids, like fentanyl and heroin, as well as cocaine—leading ...
Apr 3, 2024
0
42
Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature and resistance to chemotherapy. Exciting research published by the University of Southern Denmark sheds light on the mechanisms that ...
Apr 2, 2024
0
49
A person in Texas has been diagnosed with bird flu, an infection tied to the recent discovery of the virus in dairy cows, health officials said Monday.
Apr 1, 2024
0
55
A research team led by Associate Professor Liu Huan from the School of Humanities and Social Sciences of University of Science and Technology of China (USTC) proposes for the first time a historical periodization of the development ...
Apr 1, 2024
0
0
A safe and effective medication designed to prevent mild-to-moderate COVID-19 infections from becoming more dangerous has been available for almost two years. But recent studies have shown many patients eligible for the drug—Paxlovid—haven't ...
Apr 1, 2024
0
1
Smoking weed will soon be legal for over-18s in Germany, but addiction experts are calling for more prevention efforts to ensure young people are protected from the dangers of cannabis use.
Mar 30, 2024
0
1
A study published in Health Data Science introduces an end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field of drug discovery. This innovative framework ...
Mar 29, 2024
0
1
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
